Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression
The above findings suggest that serum adropin could be applied as a potential biomarker for predicting CKD progression in subjects with T2D. Further research is needed to validate these results and explore the underlying mechanisms.
Authors
- I-Wen Chen (ORCID: https://orcid.org/0000-0002-8928-6417)
- Chia‐Ni Lin (ORCID: https://orcid.org/0000-0001-5545-9714)
- Cheng-Wei Lin (ORCID: https://orcid.org/0000-0001-8922-7030)
- Szu-Tah Chen
Institutions
- Chang Gung University (TW)
- National Tsing Hua University (TW)
- Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.3389/fendo.2025.1511730
- Citations
- 2
- Primary Topic
- Adipose Tissue and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- Chang Gung Memorial Hospital, Linkou